Summary
Measurements by radioimmunoassay of the ANP C-terminal (Ser 99-Tyr 126), N-terminal (Asn 1-Arg 98), and cyclic GMP in plasma of 77 healthy subjects and 32 patients with labile hypertension but with diastolic pressures below 90 mmHg at time of blood sampling, 74 with mild hypertension and diastolic pressures between 90–104 mmHg, 16 with moderate hypertension and diastolic pressures between 105 and 114 mmHg, and 7 with severe hypertension and diastolic pressures above 115 mmHg were found to be within normal range in all groups of patients with untreated essential hypertension. In view of the reported increases in right and left atrial pressures in patients with mild and moderate hypertension, these findings suggest a hyporesponsiveness of the atria to release ANP in essential hypertension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Genest J, Cantin M (eds) (1988) The atrial natriuretic factor, its physiology and biochemistry. Springer, Berlin Heidelberg New York, pp 1–145
Larochelle P, Cusson JR, Gutkowska J, Schiffrin EL, Hamet P, Kuchel O, Genest J, Cantin M (1987) Plasma concentration of atrial natriuretic factor in essential and renovascular hypertension. Br Med J 294: 1249–1252
Genest J (1986) The atrial natriuretic factor. Br Heart J 56: 302–316
Genest J, Larochelle P, Cusson JR, Garcia R, Gutkowska J, Cantin M (1988) The atrial natriuretic factor in hypertension. Am J Med Sci 295: 299–304
Tsuchiya S, Ogawa K, Sataka K (1980) Plasma levels of cyclic nucleotides in patients with essential hypertension. Jpn Heart J 21: 803–815
Zachariah PK, Burnett JC, Ritter S, Strong CG (1987) Atrial natriuretic peptide in human essential hypertension. Mayo Clin Proc 62: 782–786
Kohno M, Yasunari K, Matsuura T, Murakama K, Takeda T (1987) Circulating atrial natriuretic polypeptide in essential hypertension. Am Heart J 113: 1160–1163
Nakaoka H, Kitahara Y, Amano M, Imataka K, Fujii J, Ishibashi M, Yamaji T (1987) Effect of 13-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension. Hypertension 10: 221–225
Naruse N, Naruse K, Obana K, Kurimoto F, Sakurai H, Honda T, Higashida T, Demura H, Inagami T, Shizume K (1986) Immunoreactive alpha-human atrial natriuretic polypeptide in human plasma. Peptides 7: 141–145
Andersson OK, Persson B, Aurell M, Granerus G, Wysocky M, Hedner J, Hedner T (1986) Basal and stimulated levels of immunoreactive atrial natriuretic peptide (ahANP) levels in relation to central venous pressure, renal and central hemodynamics and sodium excretion in normotensive and hypertensive man. J Cardiovasc Pharmacol 8: 1300
Hedner T, Hedner J, Towle AC, Hartford M, Ljiungram S, Wikstrand J, Berglund G (1986) Plasma atrial natriuretic peptide ( ANP) in patients with mild to moderate hypertension. J Cardiovasc Pharmacol 8: 1299
Nishiuchi T, Saito FI, Yanasaki Y, Saito S (1986) Radioimmunoassay for atrial natriuretic peptide: Method and results in normal subjects and patients with various diseases. Clin Chim Acta 159: 45–47
Nozuki M, Mouri T, Itoi K, Takahashi K, Totsune K, Saito T, Yoshinaga K (1986) Plasma concentrations of atrial natriuretic peptide in various diseases. Tohoku J Exp Med 148: 439–447
Yamaji T, Ishibashi M, Sekihara H, Takabu F, Nakaoka H, Fujii J (1986) Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension. J Clin Endocrin Metab 63: 815–818
Nilsson P, Lindholm L, Schersten B, Horn R, Melander A, Hesch RD (1987) Atrial natriuretic peptide and blood pressure in a geographically defined population. Lancet 1: 883–885
Sugawara A, Nakao K, Sakamoto M, Morii N, Yamada T, Itoh H, Shiono S, Imura H (1985) Plasma concentration of atrial natriuretic polypeptide in essential hypertension. Lancet 11: 1426–1427
Sugawara A, Nakao K, Kono T, Morii N, Yamada T, Itoh H, Shiono S, Saito Y, Mukoyama M, Arai H, Imura H (1988) Atrial natriuretic factor in essential hypertension and adrenal disorders. Hypertension 11 [Suppl 1]: 212–216
Sagnella GA, Markandu ND, Shore AC, MacGregor GA (1986) Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1: 179–181
MacGregor GA, Sagnella GA, Markandu ND, Shore AC (1986) Raised plasma levels of atrial natriuretic peptide in untreated essential hypertension. J Cardiovasc Pharmacol 8: 1301
Richards AM, Tonolo G, Davidson G (1986) Plasma atrial natriuretic peptide in essential hypertension. Proceedings, Council for High Blood Pressure Research, American Heart Association, Hypertension 8: 826
Arendt RM, Stangl E, Zahringer J, Liebisch DC, Herz A (1985) Demonstration and characterization of alpha-human atrial natriuretic factor in human plasma. FEBS Lett; 189: 57–61
Iimura O, Shimamoto K, Ando T, Ura N, Ishida H, Nakagawa M, Yokoyama T, Fukuyama S, Yamaguchi Y, Yamaji I (1987) Plasma levels of human atrial natriuretic peptide in patients with hypertensive diseases. Can J Physiol Pharmacol 65: 1701–1705
Wambach G, Bonner S, Stimpel M, Kaufmann W (1988) Relationship between plasma atrial natriuretic peptide and left atrial and left ventricular involvement in essential hypertension. J Hypertens 6: 573–577
Larochelle P, Cusson JR, Thibault G, Hamet P, Genest J, Cantin M (1989) C- and N-terminal fragments of atrial natriuretic factor in essential hypertension. Hypertension (submitted for publication)
Montorsi P, Tonolo G, Polonia J, Hepburn D, Richards AM (1987) Correlates of plasma atrial natriuretic factor in health and hypertension. Hypertension 10: 570–576
Sagnella GA, Markandu ND, Buckley MG, Shore AC, Sugden AL, Singer DRJ, MacGregor GA (1988) Plasma atrial natriuretic peptide in essential hypertension. Am J Hypertens 1: 112–118
Cusson JR, Hamet P, Gutkowska J, Kuchel O, Genest J, Cantin M, Larochelle P (1987) Effects of atrial natriuretic factor in natriuresis and cGMP in patients with essential hypertension. J Hypertens 5: 435–443
Hynynen M, Kupari M, Salmenpera M, Tikkanen I, Heinonen J, Fyhrquist F, Totterman KJ (1988) Hemodynamic effects of alpha-human atrial natriuretic peptide in healthy volunteers. J Cardiovasc Pharmacol 11: 711–715
Weidmann P, Hasler L, Gnädinger MP, Lang RE, Uehlinger DE, Shaw S, Rascher W, Reubi FC (1986) Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 77: 734–742
Zimmerman RS, Schirger JS, Edwards BS, Heublein DM, Schwab TR, Burnett JC (1987) Cardiovascular renal responses to physiologic concentrations of atrial natriuretic factor (ANF). J Am Coll Cardiol 9: 242A
London GM, Safar ME, Safar AL, Surion AC (1985) Blood pressure in the “low pressure system” and cardiac performance in essential hypertension. J Hypertens 3: 337–342
Ferlinz J (1980) Right ventricular performance in essential hypertension. Circulation 61: 157–162
Guazzi M, Fiorentini C, Olivari MP, Polese A (1979) Cardiac load and function in hypertension. Am J Cardiol 44: 1007–1012
Olivari MT, Fiorentini C, Polese A, Guazzi MD (1978) Pulmonary hemodynamics and right ventricle function in hypertension. Circulation 57: 1185–1190
Goetz KL (1987) Atrial natriuretic peptide and atrial pressure. N Engl J Med 316: 485
Raine AE, Erne P, Bürgisser E, Müller FB, Bolli P, Burkart F, Bühler FR (1986) Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 315: 533–537
Jin H, Chen YF, Yang RH, Ming QC, Oparil S (1988) Impaired release of atrial natriuretic factor in NaCl-loaded spontaneously hypertensive rats. Hypertension 11: 739–744
Greenwald JE, Sakata M, Michener ML, Sides SD, Needleman P (1988) Is atriopeptin a physiological or pathophysiological substance? Studies in the autoimmune rat. J Clin Invest 81: 1036–1041
Guyton AC, Coleman TG, Young DB, Lohmeier TE, De-Clue JW (1980) Salt-balance and long-term blood pressure control. Ann Rev Med 13: 15–27
Tobian L, Lange J, Magraw S, Coffee K (1974) Body sodium and hypertension, sodium retention by “hypertensive kidneys”. Trans Assoc Am Phys 87: 225–232
Tobian L, Johnson MA, Lange J, Magraw S (1975) Effect of varying perfusion pressures on the output of sodium and renin and the vascular resistance in kidneys of rats with “post-salt” hypertension and Kyoto spontaneous hypertension. Circ Res 36 [Suppl I]: 1162–1170
Genest J, Nowaczynski W, Kuchel O, Boucher R, Rojo-Ortega JM, Constantopoulos G, Ganten D, Messerli F (1976) The adrenal cortex and essential hypertension. Recent Progr Horm Res 32: 377–427
Collins RD, Weinberger MH, Dowdy AJ, Nokes GW, Gonzales CM, Luetscher JA (1970) Abnormally sustained aldosterone secretion during salt-loading in patients with various forms of benign hypertension: Relation to plasma renin activity. J Clin Invest 49: 1415–1426
Luetscher J, Beckerhoff R, Dowdy AJ, Wilkinson R (1972) Incomplete suppression of aldosterone secretion and plasma concentration in hypertensive patients on high sodium intake. In: Genest J, Koiw E (eds) Hypertension ’72. Springer, Berlin Heidelberg New York, pp 286–292
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Genest, J., Larochelle, P., Cusson, J.R., Cantin, M. (1989). The Atrial Natriuretic Peptide in Human Hypertension. In: Kaufmann, W., Wambach, G. (eds) Endocrinology of the Heart. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83858-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-83858-3_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-51409-1
Online ISBN: 978-3-642-83858-3
eBook Packages: Springer Book Archive